![Kevin Norrett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Norrett
Corporate Officer/Principal chez
OVID THERAPEUTICS INC.
Profil
Kevin Norrett is Chief Business Officer at Ovid Therapeutics, Inc. since 2026.
Formerly, Mr. Norrett was Chief Business Officer at Soleno Therapeutics, Inc. from 2025 to 2026, Chief Operating Officer at Codexis, Inc. from 2022 to 2025, Chief Business Officer at Sierra Oncology, Inc. from 2020 to 2022, Chief Commercial Officer at Angion Biomedica Corp.
from 2019 to 2020, Vice President-Marketing & Market Access at Aimmune Therapeutics, Inc. in 2019, VP-Market Access & Commercial Development at ZS Pharma, Inc. from 2014 to 2017, and Associate at Cowen & Co. LLC from 1999 to 2002.
Education includes graduate studies at the University of California, Los Angeles, undergraduate studies at the University of California, Davis, and an MBA from Haas School of Business.
Postes actifs de Kevin Norrett
| Sociétés | Poste | Début |
|---|---|---|
| OVID THERAPEUTICS INC. | Corporate Officer/Principal | 08/07/2026 |
Anciens postes connus de Kevin Norrett
| Sociétés | Poste | Fin |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 15/05/2026 |
| CODEXIS, INC. | Directeur des opérations | 06/11/2025 |
| SIERRA ONCOLOGY, INC. | Corporate Officer/Principal | 01/07/2022 |
| ANGN BIOM | Corporate Officer/Principal | 01/08/2020 |
| AIMMUNE THERAPEUTICS, INC. | Sales & Marketing | 01/07/2019 |
Formation de Kevin Norrett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
